Winthrop Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Winthrop Capital Management's LLY Position: Q3 2026 in Review
Winthrop Capital Management reduced its Eli Lilly (LLY) stake by 0.54% in Q3 2026, selling an estimated $114K and leaving 17,811 shares worth $20.6M. The position accounts for 5.04% of the portfolio, ranked #3.
Winthrop Capital Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $21.5M in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Winthrop Capital Management held 17,811 shares of Eli Lilly worth $20.6M as of Q3 2026.
- Winthrop Capital Management sold 97 Eli Lilly shares in Q3 2026, an estimated $114K.
- Eli Lilly made up 5.04% of Winthrop Capital Management's portfolio in Q3 2026, its #3 holding.
- Winthrop Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
- Winthrop Capital Management's Eli Lilly position peaked at $21.5M in Q2 2026.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Winthrop Capital Management's 13F filing for Q3 2026, filed 5 Nov 2026.